Glaxo CEO: Consumer health can stand on its own, but don’t expect a quick spinoff

Carly Helfand Lately, GlaxoSmithKline CEO Andrew Witty has seemed open to splitting off the industry-leading consumer health joint venture he formed with Novartis last year. But let ...

New Bayer site to make traditional Chinese and Western consumer health meds

Eric Palmer Bayer snapped up China's Dihon in 2014 with the idea of combining Dihon's traditional Chinese medicines with Bayer's Western OTC products in a major consumer ...

GSK chief Witty opens up to spinoff talk, with consumer health an obvious choice

Tracy Staton GlaxoSmithKline CEO Andrew Witty may be coming around on a breakup. At the J.P. Morgan Healthcare Conference, Witty said he's open to the idea and pegged his consumer ...

Sources: Sanofi’s Brandicourt looks at spinoff of animal health, selling supplement biz

Eric Palmer New Sanofi CEO Olivier Brandicourt has promised to unveil his 5-year strategic plan for the French drugmaker and he appears to be homing in on what to keep and ...

Drug price hawk CVS Health and the case of the $44,000 nutrition supplement

Carly Helfand CVS Health may be staring down pricey hep C drugs and forthcoming PCSK9 meds, but capsules of powdered resveratrol? Not so much. FiercePharma News

Say what? CVS Health execs figure PCSK9 meds to cost up to $150B

Tracy Staton CVS Health is raising eyebrows with a new estimate: A coming class of pricey cholesterol meds could cost the U.S. as much as $ 150 billion per year. FiercePharma ...

Ampio calls off a $30M IPO for its men’s health offshoot

Damian Garde Ampio Pharmaceuticals has postponed a plot to spin out one of its subsidiaries through an IPO, citing unfavorable market conditions. FierceBiotech News

Bayer may hive off another unit as it doubles down on pharma, consumer health

Carly Helfand Turns out it may not be just Bayer's plastics business that's on its way out the door. The company is reportedly exploring a sale of its diabetes device business ...

Take as directed? U.K. health service teams with academics, pharmacy on drug adherence

Tracy Staton It's an established fact: Many patients don't take their meds as directed. Another established fact: That failure costs the healthcare system hundreds of billions. ...

Don’t get too excited, investors: GSK has no near-term plans for consumer health spinoff

Carly Helfand Let GlaxoSmithKline be clear: It's open to spinning off its consumer healthcare division at some nebulous point in the future. But it's not happening anytime soon. FiercePharma ...

France health minister says EU will fight price of Gilead’s Sovaldi

Eric Palmer Resistance to the price that Gilead Sciences has put on Sovaldi, a drug that will cure millions of hepatitis C, is reaching a fever pitch. Now 14 European countries are ...

Sources: Bayer offers animal health biz, cash for Merck’s OTC unit

Eric Palmer When bidding wars get hot, that often springs information leaks. The latest is that there is some swap-and-shop haggling going on between Bayer and Merck over Merck's ...
Page 1 of 612345...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS